© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
Author | Brittany Lovely
Articles
Frontline Apatinib/Gefitinib Combo Improves PFS in EGFR-Mutant NSCLC
September 20, 2020
Apatinib in combination with gefitinib in the first-line setting demonstrated superior progression-free survival (PFS) in patients with advanced EGFR-mutant non–small cell lung cancer.
Xevinapant Plus CRT Improves Survival in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
September 19, 2020
The first-in-class inhibitor of apoptosis protein (IAP) antagonist significantly improved overall survival in patients with LA-SCCHN.
SOC Induces Early Response Over Avelumab in Metastatic Urothelial Carcinoma
September 19, 2020
Induction avelumab prior to standard of care led to a clinically relevant worsening of survival as the first-line treatment for patients with metastatic urothelial carcinoma.
Belantamab Mafodotin Shows Promising Response in Relapsed/Refractory Multiple Myeloma
June 03, 2020
Belantamab mafodotin monotherapy induced durable responses and appeared to be well tolerated in patients with heavily pretreated relapsed or refractory multiple myeloma.